The position verification of the radiation source utilized in brachytherapy forms a critical factor in determining the therapeutic efficiency. Currently, films are used to verify the source position; however, this method is encumbered by the lengthy time interval required from film scanning to analysis, which makes real-time position verification difficult. In general, the source position accuracy is usually tested in a monthly quality assurance check. In this context, this study investigates the feasibility of the real-time position verification of the radiation source in high dose rate (HDR) brachytherapy with the use of scintillating fibers. To this end, we construct a system consisting of scintillating fibers and a silicon photomultiplier (SiPM), optimize the dosimetric software setup and radiation system characteristics to obtain maximum measurement accuracy, and determine the relative ratio of the measured signals dependent upon the position of the scintillating fiber. According to the dosimetric results based on a treatment plan, in which the dwell time is set at 30 and 60 s at two dwell positions, the number of signals is 31.5 and 83, respectively. In other words, the signal rate roughly doubles in proportion to the dwell time. The source position can also be confirmed at the same time. With further improvements in the spatial resolution and scintillating fiber array, the source position can be verified in real-time in clinical settings with the use of a scintillating fiber-based system.
Introduction
Brachytherapy is a type of radiotherapy that is designed to remove tumors with the use of gamma or beta rays emitted from a radioisotope during its decay by positioning it close to the tumor site. 1, 2) Unlike external radiotherapy, in which healthy organs are inevitably exposed to radiation depending on the beam path, brachytherapy, also called internal radiation therapy, ensures direct dose delivery to a tumor from the radioisotope implanted near the tumor, thus radically reducing the beam path and unnecessary exposure of the surrounding healthy tissue or organs. Moreover, the average energy released during the decay of Ir-192 (which is the normally used radiation source for brachytherapy) is 380 keV, which is substantially lower than the energy range of MeV typically used for radiotherapy. Further, the beam dose decreases drastically with increasing distance from the source, thereby resulting in quasi-zero damage to healthy organs. In other words, brachytherapy can directly deliver therapeutic radiation to a tumor without radiation passing through surrounding healthy organs.
Not only does this reduce the risk of damage to healthy organs, but it also enhances the convenience of patients by re-
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-214 -ducing the total duration of radiotherapy and related costs by enabling low-fraction treatment with higher doses per fraction. 3) Since brachytherapy has demonstrated superior therapeutic efficiency for cervical, prostate, breast, and skin cancer via removal of tumors without causing any noticeable damage to healthy tissue and organs, attempts have been made to apply it to other types of cancer. 4) Given that brachytherapy involves implanting radioactive "seeds" into the body, it is noteworthy that if the seeds are not placed correctly in the planned tumor position and placed close to a healthy organ instead, the resulting radiotherapy has little therapeutic effect and the healthy organ involved is subject to the risk of developing various complications due to the delivered high-dose radiation. As such, ensuring the source position accuracy is of vital importance for the therapeutic success of brachytherapy.
5)
Plastic scintillators provide dosimetric accuracy because they have no temperature dependency in the measurement environment, and they do not "over-respond" to low-energy radiation because of the corresponding low atomic number of the plastic scintillator.
6) The plastic scintillating optical fiber used in this study also has such properties and emits scintillation light when irradiated because the microfine impurities contained in plastic react with ionizing radiation. The amount of light thus released is proportional to the energy deposited, which can be used for dose verification. 
Materials and Methods

Scintillating fiber and optical fiber
We performed dosimetry using the scintillating fiber BCF-12
and optical fiber BCF-98 (Saint-Gobain S.A., France photons/MeV, of which only about 4% are stored for signal generation.
10) The fiber emits blue light exhibiting an emission peak at 435 nm, and its signal transmission efficiency in dosimetry is improved over long fiber lengths. BCF-98, which is used as an optical fiber for transmitting the scintillating light generated from BCF-12, exhibits an average light intensity attenuation of 1 dB/m when transmitting the scintillating light of 435 mm emitted from BCF-12.
11)
SiPM-based measurement system
The abbreviation SiPM refers to the silicon photomultiplier, which is a solid-state single-photon-sensitive device based on the avalanche photodiode (APD) with an embedded photocurrent amplifier. analyzed by the Matrix-EVB Board, and the signal outputs are received at the interface of the connected PC. Besides the PC, the Matrix-EVB Communication Board is connected to a power supply to receive the operating voltage. The PC settings can be configured to optimize the pre-experimental signal measurement ( Fig. 2) so that suitable data can be selected from the measured data acquired by the Matrix-EVB Communication
Board for post-experimental result analysis (Fig. 3) .
The proposed system adopts a method of obtaining dosi- 
Central tendency of radiation data obtained using scintillating fiber and SiPM system
Given that an SiPM is more commonly used in relation to diagnostic than therapeutic radiation, we examined the characteristics and central tendency of the measurement data for therapeutic radiation using a linear accelerator before examining the signals from Ir-192, which is a commonly used radioisotope in brachytherapy.
We measured the light and signals generated from a scintillating fiber while varying the doses and dose rates of 6-MV and 10-MV photon beams using a linear accelerator and examined the central tendency of the obtained data. The source-tosurface distance (SSD) and field size (FS) were set at 100 cm and 10 cm×10 cm, respectively, for the linear accelerator.
After placing a scintillating fiber in the middle of the field and overlaying a solid water phantom with a thickness of the build-up matching 6 MV and 10 MV (i.e., for each beam condition), we examined the dose-dependent central tendency of the acquired data, increasing the dose from 20 to 50, 75, 100, and, 300 MU at a fixed dose rate of 600 MU/min. In addition, data dependency on dose rate change was examined by increasing the dose rate from 100 to 200, 300, 400, 500, and 600 MU/min at fixed doses of 6 MV and 10 MV. (Fig. 4) ; iv) measurement of the signals from each scintillating fiber using the SiPM system according to the treatment plan for the radiation source to dwell at the positions of the second and fourth scintillating fibers for 30 and 60 s, respectively. As a result, we ascertained that the proposed system could be used for source position verification and dose delivery accuracy based on the dose change that is dependent upon the dwell time at the source dwell position. (Fig. 5 ).
Dose-rate-dependency verification in dosimetry
The dose-rate-dependent signal measurement was confirmed to be constant since we obtained a low deviation of 11.43 (Fig. 6 ).
To conclude, we confirmed that almost steady data were obtained despite varying dose rates at both energy levels of 6 MV and 10 MV and that the proposed dosimetric system has no dose-rate dependency for therapeutic radiation generated by a linear accelerator.
3. Ir-192 signal measurement depending on distance from source with single scintillating fiber
We confirmed that the number of signals measured rapidly decreases (329, 204, 175, 60, 16, and 10) as the distance between the radiation source and scintillating fiber increases (0 to 0.5, 1, 1.5, 2, and 2.5 cm in that order) (Fig. 7) . This is consistent with the result of a previous study, 14) which reported 
Conclusion
In this study, we tested the reliability of a scintillating-fiberbased dosimetric system for verifying the position of a brachytherapy radiation source. Currently, the quality control of the position accuracy of a brachytherapy radiation source is not performed during each treatment session in real-time, but periodically at specified intervals. 15) Because an irradiated scintillating fiber emits light and the signal analysis can be performed on-site immediately after radiation, the time requirement for source position verification with the proposed system is drastically lesser than with conventional methods. Moreover, the readout system using scintillating fibers and a SiPM system is small and easy to use, enabling a rapid and accurate pre-treatment check of the beam path and thus enhancing dose delivery accuracy. This study was conducted to evaluate the feasibility of using a scintillating fiber for dosimetry. Given that the proposed system consists of scintillating fibers arrayed at 1-cm intervals, currently yielding a resolution insufficient for clinical use, its spatial resolution can be improved by narrowing the intervals of scintillating fibers in a follow-up study.
Furthermore, the distance between source and fiber should be reduced for more accurate signal measurement, which can be best achieved by inserting the fiber into the patient's body near the radiation source. Thus, our research team intends to develop a modified brachytherapy applicator that has an additional function of inserting a scintillating fiber. By refining the present simplified scintillating fiber array and designing the system for individual application for patients, it is expected that the source position information obtained in real-time during patient treatment can be used to prevent brachytherapy-related accidents.
